Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22328883 | 0.81 | PTPN1 (0.32) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL12577405 | 0.78 | ALOX5 (0.43) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL10443639 | 0.78 | GPR3 (0.42) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL10442566 | 0.78 | GPR3 (0.42) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL21705106 | 0.78 | CTDSP1 (0.32) | CYP1A2 | |
| SCHEMBL10442582 | 0.78 | GPR3 (0.45) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL13158704 | 0.78 | GPR3 (0.45) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL13556997 | 0.78 | GPR3 (0.48) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL12577989 | 0.78 | GPR3 (0.48) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL126453 | 0.78 | GPR3 (0.52) | GPR3ALDH1A1MAPTHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | CANON KABUSHIKI KAISHA (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | CANON KABUSHIKI KAISHA (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | OCIAD1, L1CAM, SPIN4 | GPR3 657/4885ALDH1A1 283/4885MAPT 1934/4885 |
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | OCIAD1, L1CAM, SPIN4 | GPR3 657/4885ALDH1A1 283/4885MAPT 1934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.